Free Access
Med Sci (Paris)
Volume 18, Number 10, Octobre 2002
Page(s) 965 - 973
Section M/S Revues : Articles de Synthèse
Published online 15 October 2002
  1. Ralevic V, Burnstock G. Receptors for purines and pyrimidines. Pharmacol Rev 1998; 50 : 413–92. [Google Scholar]
  2. Burnstock G. Purinemediated signalling in pain and visceral perception. Trends Pharmacol Sci 2001; 22 : 182–8. [Google Scholar]
  3. Schneider SW, Egan ME, Jena BP, Guggino WB, Oberleithner H, Geibel JP. Continuous detection of extracellular ATP on living cells by using atomic force microscopy. Proc Natl Acad Sci USA 1999; 96 : 12180–5. [Google Scholar]
  4. Watt WC, Lazarowski ER, Boucher RC. Cystic fibrosis transmembrane regulatorindependent release of ATP. J Biol Chem 1998; 273 : 14053–8. [Google Scholar]
  5. Zimmermann H. Extracellular metabolism of ATP and other nucleotides. Naunyn-Schmiedeberg’s Arch Pharmacol 2000; 362 : 299–309. [Google Scholar]
  6. Marcus AJ, Broekman MJ, Drosopoulos JH, et al. The endothelial cell ecto-ADPase responsible for inhibition of platelet function is CD39. J Clin Invest 1997; 99 : 1351–60. [Google Scholar]
  7. Enjyoji K, Sevigny J, Lin Y, et al. Targeted disruption of CD39/ATP diphosphohydrolase results in disordered hemostasis and thromboregulation. Nat Med 1999; 5 :1010–7. [Google Scholar]
  8. Leurs R, Watanabe T, Timmerman H. Histamine receptors are finally coming out. Trends Pharmacol Sci 2001; 22 : 337–9. [Google Scholar]
  9. Gaarder A, Jonsen L, Laland S, Hellem A, Owren PA. Adenosine diphosphate in red cells as a factor in the adhesiveness of human blood platelets. Nature 1961; 192 : 531–2. [Google Scholar]
  10. Gachet C. ADP receptors of platelets and their inhibition. Thromb Haemost 2001; 86 : 222–32. [Google Scholar]
  11. Trumel C, Payrastre B, Plantavid M, et al. A key role of adenosine diphosphate in the irreversible platelet aggregation induced by the PAR1-activating peptide through the late activation of phosphoinositide 3-kinase. Blood 1999; 94 : 4156–65. [Google Scholar]
  12. Fabre JE, Nguyen M, Latour A, et al. Decreased platelet aggregation, increased bleeding time and resistance to thromboembolism in P2Y1-deficient mice. Nat Med 1999; 5 : 1199–202. [Google Scholar]
  13. Leon C, Hechler B, Freund M, et al. Defective platelet aggregation and increased resistance to thrombosis in purinergic P2Y(1) receptornull mice. J Clin Invest 1999; 104 : 1731–7. [Google Scholar]
  14. Foster CJ, Prosser DM, Agans JM, et al. Molecular identification and characterization of the platelet ADP receptor targeted by thienopyridine antithrombotic drugs. J Clin Invest 2001; 107 : 1591–8. [Google Scholar]
  15. Savi P, Pereillo JM, Uzabiaga MF, et al. Identification and biological activity of the active metabolite of clopidogrel. Thromb Haemost 2000; 84 : 891–6. [Google Scholar]
  16. Humphries RG. Pharmacology of AR-C69931MX and related compounds: from pharmacological tools to clinical trials. Haematologica 2000; 85 : 66–72. [Google Scholar]
  17. Leon C, Freund M, Ravanat C, Baurand A, Cazenave JP, Gachet C. Key role of the P2Y(1) receptor in tissue factor-induced thrombindependent acute thromboembolism: studies in P2Y(1)-knockout mice and mice treated with a P2Y(1) antagonist. Circulation 2001; 103 : 718–23. [Google Scholar]
  18. Lenain N, Freund M, Léon C, Cazenave JP, Gachet C. Reduced platelet thrombus formation in arterioles of P2Y1 receptor-deficient mice. Thromb Haemost 2001; 86 (suppl) : P1926 (abstract). [Google Scholar]
  19. Olivier KN, Bennett WD, Hohneker KW, et al. Acute safety and effects on mucociliary clearance of aerosolized uridine 5’-triphosphate ± amiloride in normal human adults. Am J Respir Crit Care Med 1996; 154 : 217–23. [Google Scholar]
  20. Cressman VL, Lazarowski E, Homolya L, Boucher RC, Koller BH, Grubb BR. Effect of loss of P2Y2 receptor gene expression on nucleotide regulation of murine epithelial Cl- transport. J Biol Chem 1999; 274 : 26461–8. [Google Scholar]
  21. Li Y, Kuang K, Wen Q, Rosskothen H, Fiscbarg J. Rabbit conjunctival epithelium transports fluid and P2Y2 receptor agonists stimulate Cl- and fluid secretion. Am J Physiol 2001; 281 : C595–602. [Google Scholar]
  22. Jiang L, Foster FM, Ward P, Tasevski V, Luttrell BM, Conigrave AD. Extracellular ATP triggers cyclic AMP-dependent differentiation of HL-60 cells. Biochem Biophys Res Commun 1997; 232 : 626–30. [Google Scholar]
  23. la Sala A, Ferrari D, Corinti S, Cavani A, Di Virgilio F, Girolomoni G. Extracellular ATP induces a distorted maturation of dendritic cells and inhibits their capacity to initiate Th1 responses. J Immunol 2001; 166 :1611–7. [Google Scholar]
  24. Wilkin F, Duhant X, Bruyns C, Suarez-Huerta N, Boeynaems JM, Robaye B. The P2Y11 receptor mediates the ATP-induced maturation of human monocyte-derived dendritic cells. J Immunol 2001; 166 : 7172–7. [Google Scholar]
  25. Duhant X, Schandené L, Bruyns C, et al. Extracellular adenine nucleotides inhibit the activation of human CD4+ T lymphocytes. J Immunol 2002; 169 : 15–21. [Google Scholar]
  26. Nataraj C, Thomas DW, Tilley SL, et al. Receptors for prostaglandin E2 that regulate cellular immune responses in the mouse. J Clin Invest 2001; 108 : 1229–35. [Google Scholar]
  27. Somers GR, Hammet FMA, Trute L, Southey MC, Venter DJ. Expression of the P2Y6 purinergic receptor in human T cells infiltrating inflammatory bowel disease. Lab Invest 1998; 78 : 1375–83. [Google Scholar]
  28. Warny M, Aboudola S, Robson SC, et al. P2Y6 nucleotide receptor mediates monocyte interleukin-8 production in response to UDP or lipopolysaccharide. J Biol Chem 2001; 276 : 26051–6. [Google Scholar]
  29. Léon C, Vial C, Cazenave JP, Gachet C. Cloning and sequencing of a human cDNA encoding endothelial P2Y1 receptor. Gene 1996; 171 : 295–7. [Google Scholar]
  30. Parr CE, Sullivan DM, Paradiso AM, et al. Cloning and expression of a human P2U nucleotide receptor, a target for cystic fibrosis pharmacotherapy. Proc Natl Acad Sci USA 1994; 91 : 3275–9. [Google Scholar]
  31. Communi D, Pirotton S, Parmentier M, Boeynaems JM. Cloning and functional expression of a human uridine nucleotide receptor. J Biol Chem 1995; 270 : 30849–52. [Google Scholar]
  32. Communi D, Parmentier M, Boeynaems JM. Cloning, functional expression and tissue distribution of the human P2Y6 receptor. Biochem Biophys Res Commun 1996; 222 : 303–8. [Google Scholar]
  33. Communi D, Govaerts C, Parmentier M, Boeynaems JM. Cloning of a human purinergic receptor coupled to phospholipase C and adenylyl cyclase. J Biol Chem 1997; 272 : 31969–73. [Google Scholar]
  34. Hollopeter G, Jantzen HM, Vincent D, et al. Identification of the platelet ADP receptor targeted by antithrombotic drugs. Nature 2001; 409 : 202–6. [Google Scholar]
  35. Zhang FL, Luo L, Gustafson E, et al. ADP is the cognate ligand for the orphan G-protein coupled receptor SP1999. J Biol Chem 2001; 276 : 8608–15. [Google Scholar]
  36. Communi D, Suarez Gonzalez N, Detheux M, et al. Identification of a novel human ADP receptor coupled to Gi . J Biol Chem 2001; 276 : 41479–85. [Google Scholar]
  37. Chambers JK, Macdonald LE, Sarau HM, et al. A G-protein-coupled receptor for UDP-glucose. J Biol Chem 2000; 275 : 10767–71. [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.